Company Overview of NAL Pharmaceuticals Ltd.
NAL Pharmaceuticals Ltd. provides drug development and delivery focusing on chronic severe pain, breakthrough pain, arthritic pain, migraine, asthma, post-chemotherapy emesis, smoking cessation, wound healing, and eye care. The company’s drug delivery technologies include Bio-FX, Bio-D3, and Bio-CR. NAL Pharmaceuticals Ltd. is based in Causeway Bay, Hong Kong.
311 Gloucester Road
Causeway Bay, 999077
Key Executives for NAL Pharmaceuticals Ltd.
NAL Pharmaceuticals Ltd. does not have any Key Executives recorded.
NAL Pharmaceuticals Ltd. Key Developments
Similar Private Companies By Industry
|Antiviral Technologies, Inc.||Asia|
|Bio-Cancer Treatment International Ltd.||Asia|
|Bio-Works Company Limited||Asia|
|China Gene, Ltd. (Hong Kong)||Asia|
|DiagCor Bioscience Incorporation Limited||Asia|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|The Advertising Council, Inc.||United States|
|Rush University||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact NAL Pharmaceuticals Ltd., please visit www.nalpharma.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.